Rankings
▼
Calendar
ALKS FY 2015 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$628M
+1.5% YoY
Gross Profit
$489M
77.9% margin
Operating Income
-$224M
-35.7% margin
Net Income
-$227M
-36.2% margin
EPS (Diluted)
$-1.52
Cash Flow
Operating Cash Flow
-$40M
Free Cash Flow
-$93M
Stock-Based Comp.
$97M
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$541M
Stockholders' Equity
$1.3B
Cash & Equivalents
$181M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$628M
$619M
+1.5%
Gross Profit
$489M
$443M
+10.5%
Operating Income
-$224M
-$87M
-157.4%
Net Income
-$227M
-$30M
-655.7%
← FY 2014
All Quarters
Q1 2016 →